160 related articles for article (PubMed ID: 7848393)
1. Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome.
Stidham KR; Johnson JL; Seigler HF
Arch Surg; 1994 Mar; 129(3):316-24. PubMed ID: 7848393
[TBL] [Abstract][Full Text] [Related]
2. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
3. Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.
Majewski W; Stanienda K; Wicherska K; Ulczok R; Wydmanski J
Asian Pac J Cancer Prev; 2015; 16(14):5709-14. PubMed ID: 26320440
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.
Ingkaninanda P; Visessiri Y; Rutnin S
J Med Assoc Thai; 2015 Aug; 98(8):820-7. PubMed ID: 26437541
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in malignant melanoma of the eyelid skin.
Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S
Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, clinical Stage I.
Johnson OK; Emrich LJ; Karakousis CP; Rao U; Greco WR
Cancer; 1985 Mar; 55(5):1107-17. PubMed ID: 3967194
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
8. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
9. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
[TBL] [Abstract][Full Text] [Related]
11. Updated statistical data for malignant melanoma in Japan.
Ishihara K; Saida T; Yamamoto A;
Int J Clin Oncol; 2001 Jun; 6(3):109-16. PubMed ID: 11706778
[TBL] [Abstract][Full Text] [Related]
12. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
13. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
Karjalainen J; Eskelinen M; Kosma VM; Lipponen P; Tuominen L; Alhava E
Anticancer Res; 1992; 12(5):1507-11. PubMed ID: 1444213
[TBL] [Abstract][Full Text] [Related]
14. Melanoma survival: sex does matter, but we do not know how.
Crocetti E; Fancelli L; Manneschi G; Caldarella A; Pimpinelli N; Chiarugi A; Nardini P; Buzzoni C
Eur J Cancer Prev; 2016 Sep; 25(5):404-9. PubMed ID: 26266895
[TBL] [Abstract][Full Text] [Related]
15. Age as a prognostic factor in the malignant melanoma population.
Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
17. Acral melanoma: a review of 185 patients with identification of prognostic variables.
Slingluff CL; Vollmer R; Seigler HF
J Surg Oncol; 1990 Oct; 45(2):91-8. PubMed ID: 2214797
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.
Egberts F; Momkvist A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
Tumour Biol; 2010 Jan; 31(1):8-15. PubMed ID: 20237897
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
20. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.
Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E
Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
